Paper41258633
Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical application.
Wang S and 7 others. Discov Oncol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical application. Papers, record 41258633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41258633
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical application.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CJ20240082 | Changzhou Science and Technology Plan Project | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25417114 | Integrated genomic characterization of papillary thyroid carcinoma. | Cell | 2014 | https://conductscience.org/library/papers/25417114 | PubMed |
| 2 | 35988867 | A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35988867 | PubMed |
| 3 | 30026331 | Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis. | Cancer Res | 2018 | https://conductscience.org/library/papers/30026331 | PubMed |
| 4 | 35670968 | Lymph Node Dissection for Papillary Thyroid Carcinoma. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35670968 | PubMed |
| 5 | 32231639 | Update on Fundamental Mechanisms of Thyroid Cancer. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32231639 | PubMed |
| 6 | 35332119 | Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. | Nat Commun | 2022 | https://conductscience.org/library/papers/35332119 | PubMed |
| 7 | 28953664 | Risk factors of hypoparathyroidism following total thyroidectomy with central lymph node dissection. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28953664 | PubMed |
| 8 | 37505499 | Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37505499 | PubMed |
| 9 | 16174717 | BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. | J Clin Endocrinol Metab | 2005 | https://conductscience.org/library/papers/16174717 | PubMed |
| 10 | 18381570 | BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines. | J Clin Endocrinol Metab | 2008 | https://conductscience.org/library/papers/18381570 | PubMed |
| 11 | 32046099 | Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32046099 | PubMed |
| 12 | 36921693 | Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36921693 | PubMed |
| 13 | 36633525 | Cancer statistics, 2023. | CA Cancer J Clin | 2023 | https://conductscience.org/library/papers/36633525 | PubMed |
| 14 | 31305897 | Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer. | Endocrinology | 2019 | https://conductscience.org/library/papers/31305897 | PubMed |
| 15 | 32940362 | Cancer statistics for adolescents and young adults, 2020. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32940362 | PubMed |
| 16 | 22105775 | BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion. | Endocr Pathol | 2012 | https://conductscience.org/library/papers/22105775 | PubMed |
| 17 | 30955264 | [The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2019 | https://conductscience.org/library/papers/30955264 | PubMed |
| 18 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 19 | 19170045 | The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. | J Surg Oncol | 2009 | https://conductscience.org/library/papers/19170045 | PubMed |
| 20 | 28362912 | Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. | JAMA | 2017 | https://conductscience.org/library/papers/28362912 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41258633
GET https://conductscience.org/api/papers/v1/41258633/references?page=2